Krystal Biotech, Inc. KRYS Common Stock Shares Outstanding
Common Stock Shares Outstanding at other companies
Other financials
Where this comes from
Reported directly by Krystal Biotech, Inc. in its filing.
Tagged under the XBRL concept us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue.
The official record: Krystal Biotech, Inc.’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →
Ask your AI about Krystal Biotech, Inc.'s common stock shares outstanding.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Krystal Biotech, Inc.'s common stock shares outstanding?
- Krystal Biotech, Inc. (KRYS) reported common stock shares outstanding of $286.11M in Q1 2026.
- How has Krystal Biotech, Inc.'s common stock shares outstanding changed year-over-year?
- Krystal Biotech, Inc.'s common stock shares outstanding increased by 43.9% year-over-year, from $198.81M to $286.11M.
- What is the long-term trend for Krystal Biotech, Inc.'s common stock shares outstanding?
- Over 5 years (2020 to 2025), Krystal Biotech, Inc.'s common stock shares outstanding has grown at a 77.8% compound annual growth rate (CAGR), from $16.8M to $298.66M.